Sign In
Buy NVTA
$0.0190
+0 (+0%)
At Close: May 13, 2024
Invitae: Revolutionizing Genetic Testing
04:53am, Tuesday, 08'th Sep 2020
Invitae is hoping to democratize genetic testing by dramatically reducing prices. The company is rapidly expanding its business in order to cement a strong foothold in the fast-growing genetics market
Next Generation Cancer Diagnostics: Technologies and Global Markets (2019-2025) - ResearchAndMarkets.com
12:00am, Tuesday, 25'th Aug 2020
The
3 Important Things I've Learned Reviewing ARK's ETFs
10:53am, Monday, 24'th Aug 2020
ARK Invest currently offers some of the best performing ETFs over the past five years. The five actively managed ETFs provided by ARK cover innovation, autonomous technology and robotics, next generat
Rafferty Asset Management LLC Has $1.79 Million Stock Position in InVitae Corp (NYSE:NVTA)
09:20am, Sunday, 23'rd Aug 2020
Rafferty Asset Management LLC grew its position in InVitae Corp (NYSE:NVTA) by 120.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned
Thomas Brida Sells 12,416 Shares of InVitae Corp (NYSE:NVTA) Stock
07:40am, Saturday, 22'nd Aug 2020
InVitae Corp (NYSE:NVTA) General Counsel Thomas Brida sold 12,416 shares of the stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $32.10, for a total val
Is Invitae Corporation (NYSE:NVTA) Popular Amongst Institutions?
05:30pm, Thursday, 06'th Aug 2020
A look at the shareholders of Invitae Corporation (NYSE:NVTA) can tell us which group is most powerful. Generally...
Invitae Posts a Loss After a Revenue Decline in the Second Quarter
07:32pm, Wednesday, 05'th Aug 2020
Not all of the genetic tests it sells were particularly in demand as the COVID-19 pandemic intensified.
Invitae (NVTA) Q2 2020 Earnings Call Transcript
10:01am, Wednesday, 05'th Aug 2020
Ladies and gentlemen, thank you for standing by, and welcome to Invitae's second-quarter 2020 financial results conference call. Joining us today are Sean George, our CEO; Shelly Guyer, our CFO; Lee
Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates
10:45pm, Tuesday, 04'th Aug 2020
Invitae (NVTA) delivered earnings and revenue surprises of -24.19% and 13.23%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Invitae Reports Inducement Grants Under NYSE Rule 303A.08
10:37pm, Tuesday, 04'th Aug 2020
Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it granted restricted stock units ("RSUs") to Kenneth D. Knight, Invitae's new Chief Operating Officer and Ka
Recap: Invitae Q2 Earnings
09:15pm, Tuesday, 04'th Aug 2020
Shares of Invitae (NYSE:NVTA) fell 9.39% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share fell 48.08% over the past year to ($0.77), which missed the
Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know
09:50pm, Wednesday, 29'th Jul 2020
Invitae (NVTA) closed the most recent trading day at $29.12, moving -1.59% from the previous trading session.
Next gains but Barclays, GlaxoSmithKline head the other way in quiet London stock market
01:53pm, Wednesday, 29'th Jul 2020
London stocks had a subdued session on Wednesday, as investors waited for a Federal Reserve decision and absorbed a busy earnings reporting day, which include results from Barclays and GlaxoSmithKline
Fling Open the Doors and the Brits Will Shop
10:43am, Wednesday, 29'th Jul 2020
(Bloomberg Opinion) -- Covid-19 has not completely diminished consumer demand. That was the message from U.K. mid-market clothing retailer Next Plc on Wednesday, which revealed surprisingly resilient
